Vimarsana
Biggest News Aggregation in the World

Page 5 - Dror Ben Asher News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dror Ben Asher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dror Ben Asher Today - Breaking & Trending Today

RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results - Vimarsana News

RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results

Published: March 17, 2022

/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its operational...

Source: prnewswire.com
Related Topics:
United Arab EmiratesUnited StatesSouth KoreaUnited KingdomSouth AfricaSaudi ArabiaSouth KoreanAmber FennellDror Ben AsherRedhill BiopharmaBryan GibbsAdi FrishMicha Ben ChorinKukbo CoCalifornia Medicaid Health CareGhassan Aboud GroupRedhill Biopharma LtdNational Medicare PartDevelopment ExpensesCompany Annual Report On FormExchange CommissionCompany Expanded Access ProgramKorea Kukbo CoGaelan Medical TradeGulf Cooperation Council Region Saudi Arabia
RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results - Vimarsana News

RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results

Published: March 17, 2022

/PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its operational...

Source: prnewswire.com
Related Topics:
United Arab EmiratesUnited StatesSouth KoreaUnited KingdomSouth AfricaSaudi ArabiaSouth KoreanAmber FennellDror Ben AsherRedhill BiopharmaBryan GibbsAdi FrishMicha Ben ChorinKukbo CoCalifornia Medicaid Health CareGhassan Aboud GroupRedhill Biopharma LtdNational Medicare PartDevelopment ExpensesCompany Annual Report On FormExchange CommissionCompany Expanded Access ProgramKorea Kukbo CoGaelan Medical TradeGulf Cooperation Council Region Saudi Arabia
RedHill Biopharma Announces Record Quarterly Revenues and First Commercial Operations Breakeven - Vimarsana News

RedHill Biopharma Announces Record Quarterly Revenues and First Commercial Operations Breakeven

Published: February 17, 2022

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today provided a business update for...

Source: prnewswire.com
Related Topics:
Amber FennellDror Ben AsherRedhill BiopharmaAdi FrishInternational Financial Reporting StandardsRedhill Biopharma LtdExchange CommissionCompany Annual Report On FormCompany Expanded Access ProgramPricewaterhousecoopers InternationalBusiness DevelopmentInternational Accounting Standards BoardChief Executive OfficerHill BiopharmaPrivate Securities Litigation Reform ActInternational Accounting StandardsExpanded Access ProgramAnnual ReportBusiness Development OfficerUnited KingdomCertified Public AccountantsPricewaterhousecoopers International LimitedRedhill Biopharma Ltd
RedHill Biopharma Announces Record Quarterly Revenues and First Commercial Operations Breakeven - Vimarsana News

RedHill Biopharma Announces Record Quarterly Revenues and First Commercial Operations Breakeven

Published: February 17, 2022

TEL AVIV, Israel and RALEIGH, N.C., Feb. 17, 2022 /PRNewswire/ -- RedHill Biopharma Ltd. , a specialty biopharmaceutical company, today provided a business update for the fourth quarter of... | February 17, 2022

Source: marketscreener.com
Related Topics:
Amber FennellDror Ben AsherRedhill BiopharmaAdi FrishInternational Financial Reporting StandardsRedhill Biopharma LtdExchange CommissionCompany Annual Report On FormCompany Expanded Access ProgramPricewaterhousecoopers InternationalBusiness DevelopmentInternational Accounting Standards BoardChief Executive OfficerHill BiopharmaPrivate Securities Litigation Reform ActInternational Accounting StandardsExpanded Access ProgramAnnual ReportBusiness Development OfficerUnited KingdomCertified Public AccountantsPricewaterhousecoopers International LimitedRedhill Biopharma Ltd Stock ExchangePress ReleaseUarter Rdhl Us7574681034
RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia® for the United Arab Emirates - Vimarsana News

RedHill Biopharma and Gaelan Medical Enter Into License Agreement for Talicia® for the United Arab Emirates

Published: January 7, 2022

/PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, announced that it has entered into...

Source: prnewswire.com
Related Topics:
United StatesT Ai PeiUnited Arab EmiratesUnited KingdomSaudi ArabiaAmber FennellDror Ben AsherBryan GibbsRedhill BiopharmaGhassan AboudAdi FrishNational Cancer InstituteWorld Health OrganizationGhassan Aboud GroupLeey Asian Pacific Alliance On HelicobacterRedhill Biopharma LtdCompany Annual Report On FormExchange CommissionEnd Results ProgramCompany Expanded Access ProgramGaelan Medical TradeCorporate Business DevelopmentGulf Cooperation Council Region Saudi ArabiaPrnewswire Redhill Biopharma LtdGaelan Medical